LOCAL ADVANTAGE
GLOBAL OPPORTUNITY

Valens GroWorks Third Quarter 2019 Earnings Call

Missed the Q3 earnings call?

Visit the following link:

Listen now!


As one of the largest players in the supply chain, Valens is a world-class, premium cannabis processor and testing facility with the standards and compliance to operate at a global scale. The opportunity for you? To generate continuous, long-term return.

We’ve planted our roots
and we’re here to stay.

Contact Us Read More Investor Presentation 

Current market.
(Stock Symbols: TSXV:VGW, OTCQB:VGWCF)

$2.97
CURRENT ($)
0.00
24-hour Change ($)
0.00%
24-hour Change (%)

The world is our market.

With the ability to import and export internationally, Valens is set up for every servicing and consumer product opportunity, globally.

Public Filings

SEDAR Financial News

Multi-licensed

  • Health Canada Dealer’s License (multiple)
  • Health Canada Standard Cultivation and Processing License with B2B sales amendment
  • ISO 17025 Lab accredited – First in Canada for Cannabis
  • Thermo Fisher Scientific “Centre of Excellence for Plant-Based Science”
  • EU GMP Certification pending

Our Subsidiaries

Valens AgriTech

Premium, proprietary extraction services, and R&D

Valens Labs

Globally-recognized testing and analysis

Industry Support

Valens has received validation from a $100B company, Thermo Fisher Scientific. We’re also the preferred partner of Canopy Growth, Tilray, Organigram and other industry leaders.

Extraction Partners.

We work with a number of renowned partners who share our commitment to innovation and supreme quality.

Harvest One Logo with a bright green H and Black Harvest One text underneath
Canopy Growth logo with black text over white background and three brown trees behind; highlighting Valens partners
SpeakEasy Logo in black script-like text
GTECH Holdings Logo with dark blue text for GTEC and bright green for holdings with a green symbol
Hexo Corp Logo of word HEXO in mustard yellow
The Green Organic Dutchman Logo
Tilray Logo of Grey text with blue and orange symbol of sun
Sundial logo of three leaf outlines in blue and text beneath in blue
Organigram Logo with Blue square symbol of leaf and sun with black and blue text
Tantalus Labs Logo in black and white, with sun rays and a mountain

Strategic Partners.

Eticaan Logo of Mountains and Shooting Star circling that is a cannabis leaf all in green; one of Valens partners
Black text MediGrow Australia logo with red flower symbol
Thermo Fisher Logo for Cannabis Extraction testing services
Craftgrow Collection Logo black text

The numbers.

700,000
Medical Patients Registered in Canada by 2020
$1.2B
Canadian Medical Market Size
$4.3B
Potential Canadian Recreational sales in 2019
€115.7B
European medical and recreational markets expected growth by 2028

The Bottom Line:

With the global legal marijuana market expected to reach 146.4 billion USD by 2025, Valens is in a rare position to capitalize on international opportunities.

The Valens Advantage.

  • Full control and transparency from seed to final sale
  • Proprietary methods for extraction
  • Research and analysis grants
  • International capabilities
  • Diverse product range

What’s next?

Valens has already made significant strides. Next, we will:

  • Receive pending GMP certification
  • Geographic facility expansion
  • Commence medical sales to international markets
  • Expand Kelowna footprint

Financial Reports

Q2 2019 Q1 2019 2018 2017 2016

Stay up to date.

Sign up to receive the latest investor information and company news.

Scott Young with Investor Relations
at 705-888-2756 or [email protected].

Stay up to date.

Sign up to receive the latest investor information and company news. Download our new investor deck here!
x